Skip to main content
. 2021 May-Jun;66(3):237–245. doi: 10.4103/ijd.ijd_464_21

Table 1.

Prevalence of common cutaneous manifestations of the COVID-19 disease[14]

Cutaneous manifestation Prevalence
Chilblain-like lesions 14.3-72%
Maculopapular rash 5-70%
Urticarial lesions 7-40%
Vesicular lesions 3.77-15%
Livedoid-like lesions 6%
Petechiae/Purpura 3%